These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 11304666

  • 1. Old and new drugs used in rheumatoid arthritis: a historical perspective. Part 1: the older drugs.
    Case JP.
    Am J Ther; 2001; 8(2):123-43. PubMed ID: 11304666
    [Abstract] [Full Text] [Related]

  • 2. Disease-modifying antirheumatic drugs, including methotrexate, gold, antimalarials, and D-penicillamine.
    Conaghan PG, Brooks P.
    Curr Opin Rheumatol; 1995 May; 7(3):167-73. PubMed ID: 7612407
    [Abstract] [Full Text] [Related]

  • 3. Progress in the treatment of rheumatoid arthritis.
    Pisetsky DS, St Clair EW.
    JAMA; 2001 Dec 12; 286(22):2787-90. PubMed ID: 11735734
    [No Abstract] [Full Text] [Related]

  • 4. Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis.
    Schiff MH, Whelton A.
    Semin Arthritis Rheum; 2000 Dec 12; 30(3):196-208. PubMed ID: 11124283
    [Abstract] [Full Text] [Related]

  • 5. Disease-modifying antirheumatic drugs: gold, penicillamine, antimalarials, and sulfasalazine.
    McConkey B.
    Curr Opin Rheumatol; 1991 Jun 12; 3(3):348-54. PubMed ID: 1679342
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Disease-modifying antirheumatic drugs. Potential effects in older patients.
    Gardner G, Furst DE.
    Drugs Aging; 1995 Dec 12; 7(6):420-37. PubMed ID: 8601050
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Disease-modifying antirheumatic drugs: gold, penicillamine, antimalarials, and sulfasalazine.
    Smith MD.
    Curr Opin Rheumatol; 1990 Jun 12; 2(3):489-96. PubMed ID: 1975503
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Rheumatoid arthritis therapy: the slow-acting agents.
    Hardin JG.
    Hosp Pract (Off Ed); 1989 Jun 15; 24(6):163-8, 170, 173-8. PubMed ID: 2566617
    [No Abstract] [Full Text] [Related]

  • 13. Disease-modifying antirheumatic drugs, including methotrexate, sulfasalazine, gold, antimalarials, and penicillamine.
    Girgis L, Conaghan PG, Brooks P.
    Curr Opin Rheumatol; 1994 May 15; 6(3):252-61. PubMed ID: 7914739
    [Abstract] [Full Text] [Related]

  • 14. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 1989 Jun 30; 31(795):61-4. PubMed ID: 2567489
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Rheumatoid arthritis: a pharmacologic overview.
    Pinals RS.
    Am Fam Physician; 1988 Mar 30; 37(3):145-52. PubMed ID: 2894754
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. How do second-line agents work?
    Choy E, Kingsley G.
    Br Med Bull; 1995 Apr 30; 51(2):472-92. PubMed ID: 7552077
    [Abstract] [Full Text] [Related]

  • 20. Slow-acting anti-rheumatic drug therapy for rheumatoid arthritis.
    Clegg DO, Ward JR.
    Nurse Pract; 1987 Mar 30; 12(3):44, 49-52. PubMed ID: 2882451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.